Skip to content 
Search

Latest Stories

The silent emotional side effect of Mounjaro jabs users are just beginning to talk about

Mounjaro’s lesser-known psychological impact

Mounjaro side effects

Social media has recently drawn attention to the psychological challenges

iStock

Highlights

  • Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
  • Users report emotional side effects, including low motivation and feeling “stuck”
  • A TikTok post describing the “slow middle” of weight loss struck a chord with others
  • The injection can support weight loss of up to 20% over a year
  • Drug is now sold in UK supermarkets including Tesco and Morrisons


While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.

The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.


Now available in UK supermarket pharmacies, including Tesco and Morrisons, Mounjaro is being used more widely — but not all side effects are physical.

TikTok user describes the “slow middle” struggle

Social media has recently drawn attention to the psychological challenges that can emerge partway through treatment. TikTok creator @Swedish_Sandra described feeling emotionally flat and demotivated despite ongoing physical progress.

“It’s the period of time between the before and after photos,” she explained in a recent post. “This phase feels quiet — not the start, not the finish, just the slow middle where everything is shifting but the big change isn’t visible yet.”

Sandra encouraged others to recognise that this emotional plateau is part of the journey, calling it “the hardest bit mentally” and stressing the importance of patience and perseverance.

Users share similar experiences

Sandra’s experience resonated with many who commented on her post, saying they too had noticed a dip in motivation once the initial rapid weight loss slowed.

“I’ve been struggling for the last month wondering if all this money is worth it,” wrote one user.
“My weight loss has stalled too,” added another. “It is hard to get used to when you’re used to big drops at the start.”

Several commenters offered support and perspective, with one noting:

“Even a quarter of a pound a week is still a loss. This is the phase where the weight lost is likely fat, not just water. That’s real progress.”

Sandra responded:

“The initial excitement has died down, but those ‘boring’ moments are where the steady, lasting change happens.”

A reminder that weight loss is not linear

While Mounjaro has proven effective for weight loss, the emotional and mental health aspects of the process are increasingly part of the conversation. Users are calling for greater openness around the slower, less visible phases of the journey.

The drug remains a significant tool for people managing obesity or type 2 diabetes, but the growing number of personal accounts highlight the importance of setting realistic expectations and maintaining emotional resilience throughout treatment.

More For You

Samaritans branch closures

Samaritans currently has 22,000 listening volunteers

Alamy

Samaritans to shut 100+ branches in UK and Ireland under major restructure

Highlights

  • Samaritans plans to close at least half of its 200 branches over the next 7–10 years
  • Volunteers to be moved into larger regional hubs and remote call handling to be piloted
  • Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
  • Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
  • Final decision expected in September following consultation

Mental health charity plans shift to larger hubs and remote volunteering

Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.

The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.

Keep ReadingShow less
HPV vaccine 16 to 25

Many of those targeted missed their vaccine during school years

iStock

NHS steps up HPV vaccine rollout for young people aged 16–25

Highlights

  • NHS encourages unvaccinated people aged 16–25 to get the HPV vaccine
  • Over 418,000 school leavers in past three years missed vaccination
  • HPV vaccine protects against cervical and other related cancers
  • NHS aiming for 90% uptake among girls by 2040
  • Letters, emails, texts and NHS App alerts being used for reminders

NHS campaign targets unvaccinated young adults

The NHS is urging hundreds of thousands of young people aged 16 to 25 to come forward for the HPV vaccine, which protects against cervical and other types of cancer.

Many of those targeted missed their vaccine during school years. According to NHS England, over 418,000 children left school without receiving the HPV jab in the past three years.

Keep ReadingShow less
Bryan Johnson

He now believes that commercial interests may be at odds with his philosophical mission

Getty Images

Bryan Johnson may shut down anti-ageing startup to focus on religion

Highlights

  • Bryan Johnson, 47, is contemplating shutting down or selling his anti-ageing startup, Blueprint.
  • The biotech entrepreneur recently launched a religion called "Don’t Die."
  • He says commercial activity is undermining his philosophical credibility.
  • Blueprint has faced financial pressures but Johnson denies any crisis.

Biotech entrepreneur and longevity enthusiast Bryan Johnson has revealed he is considering shutting down or selling his anti-ageing company, Blueprint. Speaking to Wired, the 47-year-old said his priorities have shifted towards developing his newly founded religion, "Don’t Die", which he believes better aligns with his philosophical ambitions.

“I am so close to either shutting it down or selling it,” Johnson said in the interview published Monday. “I don’t need the money, and it’s a pain-in-the-ass company.”

Keep ReadingShow less
slimming jab Morrisons

The move has sparked criticism on social media

iStock

Morrisons launches £129-a-month weight loss injection service

Highlights

  • Morrisons Clinic introduces subscription service for tirzepatide injections
  • The treatment may aid weight loss of up to 20% over one year
  • Monthly subscription will increase from £129 to £159 after introductory period
  • Service includes medical assessment and regular check-ins
  • Criticism emerges over the supermarket’s continued sale of unhealthy food


Morrisons has launched an online subscription service offering weight loss injections, prompting mixed reactions from the public. The supermarket’s online health platform, Morrisons Clinic, now offers tirzepatide — also known by the brand name Mounjaro — for weight management.

Tirzepatide is primarily prescribed to treat type 2 diabetes, but has also been approved for weight loss. According to Morrisons Clinic, users may lose up to 20 per cent of their body weight over the course of a year.

Keep ReadingShow less
RSV vaccine premature babies

NHS England says premature babies are three times more likely to be hospitalised due to RSV

iStock

NHS to immunise premature babies against deadly winter virus RSV

Highlights

  • NHS to offer nirsevimab injection to 9,000 premature and high-risk babies from late September
  • Aims to protect against respiratory syncytial virus (RSV), which can cause severe illness in infants
  • Premature babies are 10 times more likely to need intensive care for RSV
  • Nirsevimab offers immediate protection and lasts for six months
  • Neo-natal units across the UK will deliver the jab

Thousands of premature and high-risk babies in the UK will soon be offered a new immunisation to protect against RSV (respiratory syncytial virus), a common winter virus that can cause serious lung infections and hospitalisation. The NHS will begin delivering the nirsevimab injection from late September, aiming to shield vulnerable infants before the colder months set in.

Premature infants at higher risk from RSV

RSV typically causes coughs and colds, but in some children — particularly those born prematurely or with underlying health conditions — it can lead to bronchiolitis, pneumonia, and breathing difficulties. NHS England says premature babies are three times more likely to be hospitalised due to RSV and ten times more likely to require intensive care compared to full-term infants.

Keep ReadingShow less